إسرائيل - العربية - Ministry of Health

dexcel ltd - omeprazole 20 mg - caplets - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

إسرائيل - العربية - Ministry of Health

dexcel ltd - metformin hydrochloride 850 mg - caplets - metformin - treatment of non-insulin diabetes mellitus not responding to dietary modification.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - repaglinide 1 mg - tablets - repaglinide - treatment of type ii diabetes.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - spironolactone 100 mg - tablets - spironolactone - edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. essential hypertention. primary hyperaldostronism. hypokalemia.

إسرائيل - العربية - Ministry of Health

abic ltd. - propranolol hydrochloride 160 mg - capsules - propranolol - management of angina pectoris. control of essential and renal hypertension and essential tremor.as an adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises. migraine prophylaxis.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - felodipine 10 mg - tablets extended release - felodipine - moderate to severe hypertension. angina pectoris.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - felodipine 2.5 mg - tablets extended release - felodipine - hypertension. angina pectoris.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - ramipril 5 mg - tablets - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

إسرائيل - العربية - Ministry of Health

sanofi - aventis israel ltd - hydrochlorothiazide 12.5 mg; ramipril 2.5 mg - tablets - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

إسرائيل - العربية - Ministry of Health

dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric